Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.
Department of Internal Medicine, Medstar Baltimore, Baltimore, MD, USA.
Int J Obstet Anesth. 2024 Aug;59:104210. doi: 10.1016/j.ijoa.2024.104210. Epub 2024 Apr 30.
Women with pulmonary hypertension (PH) have increased mortality during pregnancy and the peripartum period. An increasing number of publications suggest improvements in maternal outcomes, so we conducted a systematic review focusing on disease severity and maternal survival. After screening 9097 potential studies from 1967 to 2021, we identified 66 relevant publications. Outcomes improved continuously over time and mortality fell from 11.6% in studies published before 2015 to 8.2% in studies published after 2015. Mortality was lower in patients with mild disease (0.8%) than in those with Eisenmenger syndrome (26.2%) or idiopathic pulmonary arterial hypertension (7.4-24.0%). One major drawback of the published studies is that they define severity using echocardiographic-estimated pulmonary artery pressures, without considering more contemporary parameters. This systematic review provides new insights for preconception counseling on pregnancy risks related to PH and suggests that PH classification and severity should be carefully considered in determining an individual's pregnancy-associated risk.
患有肺动脉高压 (PH) 的女性在妊娠和围产期的死亡率增加。越来越多的研究表明,产妇结局有所改善,因此我们进行了一项系统评价,重点关注疾病严重程度和产妇生存率。从 1967 年到 2021 年,我们筛选了 9097 项潜在研究,确定了 66 项相关出版物。研究结果显示,随着时间的推移,结局不断改善,死亡率从 2015 年之前发表的研究中的 11.6%下降到 2015 年之后发表的研究中的 8.2%。轻度疾病患者(0.8%)的死亡率低于艾森曼格综合征(26.2%)或特发性肺动脉高压(7.4-24.0%)患者。已发表研究的一个主要缺点是,它们使用超声心动图估计的肺动脉压力来定义严重程度,而没有考虑到更现代的参数。本系统评价为与 PH 相关的妊娠风险的孕前咨询提供了新的见解,并表明在确定个体与妊娠相关的风险时,应仔细考虑 PH 分类和严重程度。